P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Acadia acquires global rights to Trofinetide

Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome – Expanded agreement follows Acadia’s April 2023 U.S. launch of DAYBUE™ (trofinetide) as the first and only… Read More

Run4Rett – Save the Date

Mark your Calendars for our Annual   SUNDAY, SEPTEMBER 22nd, 2024 Location Richvale Community Centre, 160 Avenue Road, Richmond Hill, Ontario, L4C 5L8   Stay connected with Ontario Rett syndrome Association for more details. Feel free to sign-up… Read More

2023 IRSF Scientific Meeting Review

Dear Members:  It was a pleasure to attend the International Rett Syndrome Foundation (IRSF) scientific meeting held in Nashville June  5-7, 2023. The meeting consisted of both poster and oral presentation sessions and breakout discussions focused on basic,… Read More